147 related articles for article (PubMed ID: 6409684)
21. Endocrine and clinical effects of estradiol and testosterone pellets used in long-term replacement therapy.
Kapetanakis E; Dmowski WP; Auletta F; Scommegna A
Int J Gynaecol Obstet; 1982 Oct; 20(5):387-99. PubMed ID: 6128271
[TBL] [Abstract][Full Text] [Related]
22. Reproductive history in relation to plasma hormone levels in healthy post-menopausal women.
Ness RB; Buhari A; Gutai J; Kuller LH
Maturitas; 2000 May; 35(2):149-57. PubMed ID: 10924841
[TBL] [Abstract][Full Text] [Related]
23. Endocrine impact of pure estradiol replacement in postmenopausal women: alterations in anterior pituitary hormone release and circulating sex steroid hormone concentrations.
Veldhuis JD; Samojlik E; Evans WS; Rogol AD; Ridgeway CE; Crowley WF; Kolp L; Checinska E; Kirschner MA; Thorner MO
Am J Obstet Gynecol; 1986 Aug; 155(2):334-9. PubMed ID: 3740150
[TBL] [Abstract][Full Text] [Related]
24. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
[TBL] [Abstract][Full Text] [Related]
25. Effect of dietery weight loss on sex steroid binding sex steroids, and gonadotropins in obese postmenopausal women.
O'Dea JP; Wieland RG; Hallberg MC; Llerena LA; Zorn EM; Genuth SM
J Lab Clin Med; 1979 Jun; 93(6):1004-8. PubMed ID: 571447
[TBL] [Abstract][Full Text] [Related]
26. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
27. Periovulatory follicular fluid hormone levels in spontaneous human cycles.
Seibel MM; Smith D; Dlugi AM; Levesque L
J Clin Endocrinol Metab; 1989 Jun; 68(6):1073-7. PubMed ID: 2498380
[TBL] [Abstract][Full Text] [Related]
28. The epidemiology of serum sex hormones in postmenopausal women.
Cauley JA; Gutai JP; Kuller LH; LeDonne D; Powell JG
Am J Epidemiol; 1989 Jun; 129(6):1120-31. PubMed ID: 2729251
[TBL] [Abstract][Full Text] [Related]
29. Ovarian steroid secretion in postmenopausal women with and without endometrial cancer.
Nagamani M; Hannigan EV; Dillard EA; Van Dinh T
J Clin Endocrinol Metab; 1986 Mar; 62(3):508-12. PubMed ID: 3944235
[TBL] [Abstract][Full Text] [Related]
30. Plasma hormones in clomiphene citrate therapy.
Wu CH
Obstet Gynecol; 1977 Apr; 49(4):443-8. PubMed ID: 857209
[TBL] [Abstract][Full Text] [Related]
31. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
32. Effect of gonadotrophin-releasing hormone analogue (GnRH-A) administration on serum gonadotrophin and steroid levels in patients with polycystic ovarian disease.
Mongioi A; Maugeri G; Macchi M; Calogero A; Vicari E; Coniglione F; Aliffi A; Sipione C; D'Agata R
Acta Endocrinol (Copenh); 1986 Feb; 111(2):228-34. PubMed ID: 3082098
[TBL] [Abstract][Full Text] [Related]
33. Early menopausal changes in bone mass and sex steroids.
Johnston CC; Hui SL; Witt RM; Appledorn R; Baker RS; Longcope C
J Clin Endocrinol Metab; 1985 Nov; 61(5):905-11. PubMed ID: 3930555
[TBL] [Abstract][Full Text] [Related]
34. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
Chakravarti S; Collins WP; Thom MH; Studd JW
Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
[TBL] [Abstract][Full Text] [Related]
35. Endocrine and ovarian parameters at various frequencies of ovulation in adolescents.
Venturoli S; Fabbri R; Porcu E; Paradisi R; Orsini LF; Brondelli L; Ruggeri S; Flamigni C
Arch Gynecol Obstet; 1989; 246(2):107-14. PubMed ID: 2510614
[TBL] [Abstract][Full Text] [Related]
36. Steroid and gonadotropin levels in women during the peri-menopausal years.
Longcope C; Franz C; Morello C; Baker R; Johnston CC
Maturitas; 1986 Oct; 8(3):189-96. PubMed ID: 3097458
[TBL] [Abstract][Full Text] [Related]
37. Patterns of luteinizing and follicle-stimulating hormone pulsatility in menopausal women: correlation with plasma testosterone level and vasomotor instability episodes.
Fossum GT; Greep N; Kletzky OA
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):795-800. PubMed ID: 7573246
[TBL] [Abstract][Full Text] [Related]
38. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
39. Sex hormone status in women suffering from rheumatoid arthritis.
Cutolo M; Balleari E; Giusti M; Monachesi M; Accardo S
J Rheumatol; 1986 Dec; 13(6):1019-23. PubMed ID: 3104587
[TBL] [Abstract][Full Text] [Related]
40. Androgens and the menopause; a study of 40-60-year-old women.
Bancroft J; Cawood EH
Clin Endocrinol (Oxf); 1996 Nov; 45(5):577-87. PubMed ID: 8977755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
